Financial results - NCI BIOMEDICAL SOLUTION SRL

Financial Summary - Nci Biomedical Solution Srl
Unique identification code: 36142944
Registration number: J2016001006033
Nace: 4619
Sales - Ron
-
Net Profit - Ron
-1.321
Employees
1
Open Account
Company Nci Biomedical Solution Srl with Fiscal Code 36142944 recorded a turnover of 2024 of - , with a net profit of -1.321 and having an average number of employees of 1. The company operates in the field of Intermedieri în comerţul cu produse diverse having the NACE code 4619.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Nci Biomedical Solution Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - 0 221.334 116.931 312.263 274.467 31.282 0 0 0
Total Income - EUR - 925 225.450 119.880 321.432 285.075 38.232 7.299 6.220 732
Total Expenses - EUR - 1.326 58.375 28.909 65.824 105.375 46.266 8.625 5.812 2.053
Gross Profit/Loss - EUR - -402 167.075 90.971 255.608 179.700 -8.034 -1.326 408 -1.321
Net Profit/Loss - EUR - -420 160.434 87.463 247.273 173.438 -8.782 -1.326 346 -1.321
Employees - 0 0 0 0 0 0 0 0 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Nci Biomedical Solution Srl

Rating financiar

Financial Rating -
NCI BIOMEDICAL SOLUTION SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Nci Biomedical Solution Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Nci Biomedical Solution Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Nci Biomedical Solution Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Nci Biomedical Solution Srl - CUI 36142944

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - 86 0 0 0 162.917 137.825 118.502 118.143 117.482
Current Assets - 124.983 170.804 238.766 421.338 449.430 406.968 395.680 384.075 545.139
Inventories - 24.110 5.589 16.790 1.142 64 111.804 112.151 111.811 111.186
Receivables - 67.598 126.849 88.851 292.912 370.800 219.520 161.092 138.386 285.993
Cash - 33.275 38.366 133.126 127.283 78.565 75.643 122.436 133.877 147.960
Shareholders Funds - -376 160.065 218.189 417.499 583.022 540.271 530.162 518.133 494.250
Social Capital - 45 44 43 42 41 40 41 40 40
Debts - 125.446 10.740 20.577 3.839 29.325 4.522 3.770 3.775 187.951
Income in Advance - 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4619 - 4619"
CAEN Financial Year 4619
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 545.139 euro in 2024 which includes Inventories of 111.186 euro, Receivables of 285.993 euro and cash availability of 147.960 euro.
The company's Equity was valued at 494.250 euro, while total Liabilities amounted to 187.951 euro. Equity decreased by -20.987 euro, from 518.133 euro in 2023, to 494.250 in 2024.

Risk Reports Prices

Reviews - Nci Biomedical Solution Srl

Comments - Nci Biomedical Solution Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.